Current Issue
Commentary
Commentary on Lahiri et al. Weight and Body Mass Index Change After Switching to Integrase Inhibitors or Tenofovir Alafenamide Among Women Living with HIV
J AIDS HIV Treat, 2021, 3, 21 - 23
Francesca Macaluso, Deborah R. Gustafson
[DOI No.: https://doi.org/10.33696/AIDS.3.016]
Commentary
Commentary – HIV-Induced Extracranial Carotid Ectasia and Stroke
J AIDS HIV Treat, 2021, 3, 24 - 26
Rakhee Lalla, Prashant Raghavan, John W. Cole
[DOI No.: https://doi.org/10.33696/AIDS.3.017]
Mini Review
Pre-Exposure Prophylaxis (PrEP) Safety and Tolerability in Individuals ? 45 Years Old
J AIDS HIV Treat, 2021, 3, 27 - 30
Emily Comstock, Camilia James, Robert Hegarty, Yolanda Flores, Anthony Amoroso, Rohit Talwani, Eleanor Wilson
[DOI No.: https://doi.org/10.33696/AIDS.3.018]
Commentary
Fostemsavir in Heavily Treatment-Experienced Individuals Living with HIV-1: Insights from the Phase 3 BRIGHTE Study
J AIDS HIV Treat, 2021, 3, 31 - 36
Max Lataillade, Peter Ackerman, Till Schoofs, Andrew Clark, Michael Kozal
[DOI No.: https://doi.org/10.33696/AIDS.3.019]
Commentary
Toward Personalized Medicine for HIV/AIDS
J AIDS HIV Treat, 2021, 3, 37 - 41
Carla M. Kumbale, Eberhard O. Voit